To investigate the localization and distribution of cytochrome P450 CYP1B1 protein expression in patients diagnosed with prostate carcinoma compared to those with bladder carcinoma. To validate CYP1B1 as a molecular target for the development of selective cancer therapeutics for use in combination with radiation
AbstractThe expression of CYP1B1 has been identified in breast cancer using the reverse transcriptas...
Cytochrome P450 CYP1B1 is a member of a superfamily of haemoproteins that are central to the oxidati...
The expression of cytochrome P450 (CYP)-dependent mono-oxygenases in the prostate is important, as i...
To investigate the localization and distribution of cytochrome P450 CYP1B1 protein expression in pat...
Cytochrome P450 1B1 (CYP1B1) is recognized as a universal tumor biomarker and a feasible therapeutic...
This study is comprised of three parts including: (1) clinical validation of cytochrome P450 CYP1B1 ...
The cytochrome P450 CYP1A1 and CYP1B1 enzymes are involved in carcinogenesis via activation of pro-c...
Oral Squamous Cell Carcinoma (OSCC) has a very flagitious treatment regime. A prodrug approach is th...
Prostate cancer (CaP) mostly occurs in the peripheral zone whereas benign prostatic hypertrophy (BPH...
BACKGROUND: The cytochrome P450 CYP1A1 and CYP1B1 enzymes are involved in carcinogenesis via activat...
The prostate is conventionally divided into zones. Prostate adenocarcinoma (CaP) is commonly confine...
Introduction The prostate is a composite organ divided into zones. Prostate adenocarcinoma (CaP) mos...
The concept of overexpression of individual forms of cy-tochrome P450 enzymes in tumor cells is now ...
This article has been accepted for publication in the Journal of Biomolecular Screening.Cytochrome P...
Prostate cancer is the second leading cause of cancer deaths among men in the United States. It has ...
AbstractThe expression of CYP1B1 has been identified in breast cancer using the reverse transcriptas...
Cytochrome P450 CYP1B1 is a member of a superfamily of haemoproteins that are central to the oxidati...
The expression of cytochrome P450 (CYP)-dependent mono-oxygenases in the prostate is important, as i...
To investigate the localization and distribution of cytochrome P450 CYP1B1 protein expression in pat...
Cytochrome P450 1B1 (CYP1B1) is recognized as a universal tumor biomarker and a feasible therapeutic...
This study is comprised of three parts including: (1) clinical validation of cytochrome P450 CYP1B1 ...
The cytochrome P450 CYP1A1 and CYP1B1 enzymes are involved in carcinogenesis via activation of pro-c...
Oral Squamous Cell Carcinoma (OSCC) has a very flagitious treatment regime. A prodrug approach is th...
Prostate cancer (CaP) mostly occurs in the peripheral zone whereas benign prostatic hypertrophy (BPH...
BACKGROUND: The cytochrome P450 CYP1A1 and CYP1B1 enzymes are involved in carcinogenesis via activat...
The prostate is conventionally divided into zones. Prostate adenocarcinoma (CaP) is commonly confine...
Introduction The prostate is a composite organ divided into zones. Prostate adenocarcinoma (CaP) mos...
The concept of overexpression of individual forms of cy-tochrome P450 enzymes in tumor cells is now ...
This article has been accepted for publication in the Journal of Biomolecular Screening.Cytochrome P...
Prostate cancer is the second leading cause of cancer deaths among men in the United States. It has ...
AbstractThe expression of CYP1B1 has been identified in breast cancer using the reverse transcriptas...
Cytochrome P450 CYP1B1 is a member of a superfamily of haemoproteins that are central to the oxidati...
The expression of cytochrome P450 (CYP)-dependent mono-oxygenases in the prostate is important, as i...